Targeting the motor end plates in the mouse hindlimb gives access to a greater number of spinal cord motor neurons: An approach to maximize retrograde transport

Neuroscience

Volumn 274, Issue , 2014, Pages 318-330

  Mohan, R ^a   Tosolini, A P ^a   Morris, R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Fluoro Gold; Motor end plates; Motor neurons; Mouse hindlimb; Muscles; Retrograde transport

Indexed keywords

FLUOROGOLD; 2-HYDROXY-4,4'-DIAMIDINOSTILBENE, METHANESULFONATE SALT; STILBAMIDINE;

ANIMAL TISSUE; ARTICLE; BICEPS BRACHII MUSCLE; BICEPS FEMORIS MUSCLE; BIOAVAILABILITY; CELLULAR DISTRIBUTION; CYTOARCHITECTURE; GASTROCNEMIUS MUSCLE; GLUTEUS MAXIMUS MUSCLE; GRACILIS MUSCLE; HINDLIMB; HISTOLOGY; MALE; MOTONEURON; MOUSE; NERVE ENDING; NEUROANATOMY; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; SPINAL CORD; TIBIALIS ANTERIOR MUSCLE; VASTUS LATERALIS MUSCLE; VASTUS MEDIALIS MUSCLE; ANIMAL; C57BL MOUSE; CYTOLOGY; INNERVATION; NEUROANATOMICAL TRACT TRACING; PROCEDURES; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; HINDLIMB; MALE; MICE, INBRED C57BL; MOTOR ENDPLATE; MOTOR NEURONS; MUSCLE, SKELETAL; NEUROANATOMICAL TRACT-TRACING TECHNIQUES; SPINAL CORD; STILBAMIDINES;

EID: 84902689663     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.05.045     Document Type: Article

References (50)

1. Acsadi G., Anguelov R.A., Yang H., Toth G., Thomas R., Jani A., Wang Y., Ianakova E., Mohammad S., Lewis R.A., et al. Increased survival and function of SOD1 mice after Glial Cell-derived Neurotrophic Factor gene therapy. Hum Gene Ther 2002, 13:1047-1059.
2. Azzouz M., Ralph G.S., Storkebaum E., Walmsley L.E., Mitrophanous K.A., Kingsman S.M., Carmeliet P., Mazarakis N.D. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004, 429:413-417.
3. Baumgartner B.J., Shine H.D. Neuroprotection of spinal motoneurons following targeted transduction with an adenoviral vector carrying the gene for glial cell line-derived neurotrophic factor. Exp Neurol 1998, 153:102-112.
4. Bácskai T., Fu Y., Sengul G., Rusznák Z., Paxinos G., Watson C. Musculotopic organization of the motor neurons supplying forelimb and shoulder girdle muscles in the mouse. Brain Struct Funct 2013, 218:221-238.
5. Bácskai T., Rusznák Z., Paxinos G., Watson C. Musculotopic organization of the motor neurons supplying the mouse hindlimb muscles: a quantitative study using Fluoro-Gold retrograde tracing. Brain Struct Funct 2014, 219:303-321.
6. Bendiksen F.S., Dahl H.A., Teig E. Innervation pattern of different types of muscle fibres in the human thyroarytenoid muscle. Acta Otolaryngol 1981, 91:391-397.
7. Benedusi V., Martorana F., Brambilla L., Maggi A., Rossi D. The peroxisome proliferator-activated receptor (PPAR) controls natural protective mechanisms against lipid peroxidation in amyotrophic lateral sclerosis. J Biol Chem 2012, 287:35899-35911.
8. Benkhelifa-Ziyyat S., Besse A., Roda M., Duque S., Astord S., Carcenac R., Marais T., Barkats M. Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice. Mol Ther 2013, 21:282-290.
9. Chin T., Nattrass G.R., Selber P., Graham H.K. Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy - a comparison between manual needle placement and placement guided by electrical stimulation. J Pediatr Orthop 2005, 25:286-291.
10. Christensen E. Topography of terminal motor innervation in striated muscles from stillborn infants. Am J Phys Med 1959, 38:65-78.
11. Coonan J.R., Bartlett P.F., Galea M.P. Role of EphA4 in defining the position of a motoneuron pool within the spinal cord. J Compd Neurol 2003, 458:98-111.
12. Duxson M.J., Sheard P.W. Formation of new myotubes occurs exclusively at the multiple innervation zones of an embryonic large muscle. Dev Dyn 1995, 204:391-405.
13. Federici T., Boulis N.M. Gene therapy for amyotrophic lateral sclerosis. Neurobiol Dis 2012, 48:236-242.
14. Flood D.G., Reaume A.G., Gruner J.A., Hoffman E.K., Hirsch J.D., Lin Y.-G., Dorfman K.S., Scott R.W. Hindlimb motor neurons require Cu/Zn superoxide dismutase for maintenance of neuromuscular junctions. Am J Pathol 1999, 155:663-672.
15. Gifondorwa D.J., Jimenz-Moreno R., Hayes C.D., Rouhani H., Robinson M.B., Strupe J.L., Caress J., Milligan C. Administration of recombinant heat shock protein 70 delays peripheral muscle denervation in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neurol Res Int 2012, 2012:170426.
16. Gould T.W., Oppenheim R.W. Motor neuron trophic factors: therapeutic use in ALS?. Brain Res Rev 2011, 67:1-39.
17. Gracies J.M., Lugassy M., Weisz D.J., Vecchio M., Flanagan S., Simpson D.M. Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study. YAPMR 2009, 90(9-16):e2.
18. Greene, EC (1935) Anatomy of the rat. Transactions of the American Philosophical Society. New Series, Vol. 27, pp ii-vii+ ix-xi+ 1-370.
19. Happak W., Liu J., Burggasser G., Flowers A., Gruber H., Freilinger G. Human facial muscles: dimensions, motor endplate distribution, and presence of muscle fibres with multiple motor endplates. Anat Rec 1997, 249:276-284.
20. Henriques A., Pitzer C., Dittgen T., Klugmann M., Dupuis L., Schneider A. CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit. Mol Ther 2011, 19:284-292.
21. Hollyday M. Organization of motor pools in the chick lumbar lateral motor column. J Compd Neurol 1980, 194:143-170.
22. Hsieh-Li H.M., Chang J.G., Jong Y.J., Wu M.H., Wang N.M., Tsai C.H., Li H. A mouse model for spinal muscular atrophy. Nat Genet 2000, 24:66-70.
23. Ishiyama T., Okada R., Nishibe H., Mitsumoto H., Nakayama C. Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease. Brain Res 2004, 1019:226-236.
24. Jarcho L.W., Eyzaguirre C., Berman B., Lilienthal J.L. Spread of excitation in skeletal muscle some factors contributing to the form of the electromyogram. Am J Physiol 1952, 168:446-457.
25. Kanning K.C., Kaplan A., Henderson C.E. Motor neuron diversity in development and disease. Annu Rev Neurosci 2010, 33:409-440.
26. Kaspar B.K., Lládo J., Sherkat N., Rothstein J.D., Gage F.H. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 2003, 301:839-842.
27. Kimura E., Li S., Gregorevic P., Fall B.M., Chamberlain J.S. Dystrophin delivery to muscles of mdx mice using lentiviral vectors leads to myogenic progenitor targeting and stable gene expression. Mol Ther 2010, 18:206-213.
28. Krakora D., Macrander C., Suzuki M. Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis. Neurol Res Int 2012, 2012:379657.
29. Kumar V.P., Liu J., Lau H.K., Pereira B.P., Shen Y., Pho R.W. Neurovascular supply of the gracilis muscle: a study in the monkey and human. Plast Reconstr Surg 1998, 101:1854-1860.
30. Lateva Z.C., McGill K.C., Johanson M.E. Electrophysiological evidence of adult human skeletal muscle fibres with multiple endplates and polyneuronal innervation. J Physiol (Lond) 2002, 544:549-565.
31. Li W., Brakefield D., Pan Y., Hunter D., Myckatyn T.M., Parsadanian A. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS. Exp Neurol 2007, 203:457-471.
32. McHanwell S., Biscoe T.J. The localization of motoneurons supplying the hindlimb muscles of the mouse. Philos Trans Royal Soc B: Biol Sci 1981, 293:477-508.
33. Mohajeri M.H., Figlewicz D.A., Bohn M.C. Selective loss of alpha motoneurons innervating the medial gastrocnemius muscle in a mouse model of amyotrophic lateral sclerosis. Exp Neurol 1998, 150:329-336.
34. Nakajima H., Uchida K., Kobayashi S., Inukai T., Yayama T., Sato R., Mwaka E., Baba H. Target muscles for retrograde gene delivery to specific spinal cord segments. Neurosci Lett 2008, 435:1-6.
35. Ngo S.T., Baumann F., Ridall P.G., Pettitt A.N., Henderson R.D., Bellingham M.C., McCombe P.A. The relationship between Bayesian motor unit number estimation and histological measurements of motor neurons in wild-type and SOD1(G93A) mice. Clin Neurophysiol 2012, 123:2080-2091.
36. Nicolopoulos-Stournaras S., Iles J.F. Motor neuron columns in the lumbar spinal cord of the rat. J Compd Neurol 1983, 217:75-85.
37. Périé S, St Guily JL, Callard P, Sebille A (1997). Innervation of adult human laryngeal muscle fibres. J Neurol Sci 149:81-86.
38. Pratt S.J.P., Shah S.B., Ward C.W., Inacio M.P., Stains J.P., Lovering R.M. Effects of in vivo injury on the neuromuscular junction in healthy and dystrophic muscles. J Physiol (Lond) 2013, 591:559-570.
39. Schmued L.C., Fallon J.H. Fluoro-Gold: a new fluorescent retrograde axonal tracer with numerous unique properties. Brain Res 1986, 377:147-154.
40. Shaari C.M., Sanders I. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis. Muscle Nerve 1993, 16:964-969.
41. Suzuki M., McHugh J., Tork C., Shelley B., Hayes A., Bellantuono I., Aebischer P., Svendsen C.N. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther 2008, 16:2002-2010.
42. Tosolini A.P., Morris R. Spatial characterization of the motor neuron columns supplying the rat forelimb. Neuroscience 2012, 200:19-30.
43. Tosolini A.P., Mohan R., Morris R. Targeting the full length of the motor end plate regions in the mouse forelimb increases the uptake of Fluoro-Gold into corresponding spinal cord motor neurons. Front Neurol 2013, 4:1-10.
44. Turner B.J., Parkinson N.J., Davies K.E., Talbot K. Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model. Neurobiol Dis 2009, 34:511-517.
45. Uchida K., Nakajima H., Hirai T., Yayama T., Chen K., Guerrero A.R., Johnson W.E., Baba H. The retrograde delivery of adenovirus vector carrying the gene for brain-derived neurotrophic factor protects neurons and oligodendrocytes from apoptosis in the chronically compressed spinal cord of twy/twy mice. Spine 2012, 37:2125-2135.
46. Van Campenhout A., Molenaers G. Localization of the motor endplate zone in human skeletal muscles of the lower limb: anatomical guidelines for injection with botulinum toxin. Dev Med Child Neurol 2010, 53:108-119.
47. Vanderhorst V.G., Holstege G. Organization of lumbosacral motoneuronal cell groups innervating hindlimb, pelvic floor, and axial muscles in the cat. J Compd Neurol 1997, 382:46-76.
48. Watson C, Paxinos G, Kayalioglu G, Heise C (2009) "Atlas of the mouse spinal cord", in spinal cord: a Christopher and Dana Reeve Foundation Text and Atlas (Watson C, Paxinos G, Kayalioglu G, eds), pp. 308-379. San Diego: Elsevier.
49. Wegorzewska I., Bell S., Cairns N.J., Miller T.M., Baloh R.H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA 2009, 106:18809-18814.
50. Wu R., Wang H., Xia X., Zhou H., Liu C., Castro M., Xu Z. Nerve injection of viral vectors efficiently transfers transgenes into motor neurons and delivers RNAi therapy against ALS. Antioxid Redox Signal 2009, 11:1523-1534.